Literature DB >> 32057301

Serum alanine aminotransferase flares in chronic hepatitis B infection: the good and the bad.

Marc G Ghany1, Jordan J Feld2, Kyong-Mi Chang3, Henry L Y Chan4, Anna S F Lok5, Kumar Visvanathan6, Harry L A Janssen7.   

Abstract

Chronic hepatitis B virus (HBV) infection follows a dynamic and variable course. At different stages in the disease, hepatitis flares might occur, which can be challenging to predict and manage. Flares are believed to be primarily immune-mediated and might mark transitions to inactive disease or clearance of infection, but in certain scenarios they might also lead to hepatic decompensation or death. As such, understanding of the clinical significance of flares in different patient populations and different scenarios is important for optimal management. In this Review, we summarise what is known about flares in different stages of chronic HBV infection; describe flares in the context of the natural history of chronic infection; summarise the immunological mechanisms underlying flares, and describe flares in different clinical scenarios. Each section reviews existing knowledge and highlights key unanswered questions that need to be addressed to improve the understanding of flares, hopefully providing insights into their pathogenesis that can be used to improve current clinical management and ideally to further develop new curative therapeutic approaches for HBV infection. We also propose a working definition of an ALT flare to facilitate future research.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32057301      PMCID: PMC7158588          DOI: 10.1016/S2468-1253(19)30344-9

Source DB:  PubMed          Journal:  Lancet Gastroenterol Hepatol


  93 in total

1.  Cost-Effectiveness Analysis of Hepatitis B Virus Screening and Management in Patients With Hematologic or Solid Malignancies Anticipating Immunosuppressive Cancer Therapy.

Authors:  Jessica P Hwang; Danmeng Huang; John M Vierling; Maria E Suarez-Almazor; Ya-Chen Tina Shih; Mariana Chavez-MacGregor; Zhigang Duan; Sharon H Giordano; Dawn L Hershman; Michael J Fisch; Scott B Cantor
Journal:  JCO Clin Cancer Inform       Date:  2019-03

2.  A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection.

Authors:  Guo-Rong Han; Min-Kai Cao; Wei Zhao; Hong-Xiu Jiang; Cui-Min Wang; Shu-Fen Bai; Xin Yue; Gen-Ju Wang; Xun Tang; Zhi-Xun Fang
Journal:  J Hepatol       Date:  2011-04-15       Impact factor: 25.083

3.  B cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus-associated acute liver failure.

Authors:  Patrizia Farci; Giacomo Diaz; Zhaochun Chen; Sugantha Govindarajan; Ashley Tice; Liane Agulto; Stefania Pittaluga; Denali Boon; Claro Yu; Ronald E Engle; Mark Haas; Richard Simon; Robert H Purcell; Fausto Zamboni
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-26       Impact factor: 11.205

4.  Antiviral therapy for chronic hepatitis B in pregnancy.

Authors:  Calvin Q Pan; Hannah M Lee
Journal:  Semin Liver Dis       Date:  2013-06-08       Impact factor: 6.115

5.  Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients.

Authors:  Zheng Zhang; Shuye Zhang; Zhengsheng Zou; Jianfei Shi; Juanjuan Zhao; Rong Fan; Enqiang Qin; Baosen Li; Zhiwei Li; Xiangsheng Xu; Junliang Fu; Jiyuan Zhang; Bin Gao; Zhigang Tian; Fu-Sheng Wang
Journal:  Hepatology       Date:  2010-10-26       Impact factor: 17.425

6.  A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B.

Authors:  Anthony T Tan; Sarene Koh; Winnie Goh; Heng Yee Zhe; Adam J Gehring; Seng Gee Lim; Antonio Bertoletti
Journal:  J Hepatol       Date:  2010-01-13       Impact factor: 25.083

7.  Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women.

Authors:  K M Neuzil; G W Reed; E F Mitchel; L Simonsen; M R Griffin
Journal:  Am J Epidemiol       Date:  1998-12-01       Impact factor: 4.897

8.  PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection.

Authors:  Loghman Salimzadeh; Nina Le Bert; Charles-A Dutertre; Upkar S Gill; Evan W Newell; Christian Frey; Magdeleine Hung; Nikolai Novikov; Simon Fletcher; Patrick Tf Kennedy; Antonio Bertoletti
Journal:  J Clin Invest       Date:  2018-08-07       Impact factor: 14.808

9.  A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: a randomized trial.

Authors:  Chiun Hsu; Chao A Hsiung; Ih-Jen Su; Wei-Shou Hwang; Ming-Chung Wang; Sheng-Fung Lin; Tseng-Hsi Lin; Hui-Hua Hsiao; Ji-Hsiung Young; Ming-Chih Chang; Yu-Min Liao; Chi-Cheng Li; Hung-Bo Wu; Hwei-Fang Tien; Tsu-Yi Chao; Tsang-Wu Liu; Ann-Lii Cheng; Pei-Jer Chen
Journal:  Hepatology       Date:  2008-03       Impact factor: 17.425

10.  Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes.

Authors:  S Van Hees; S Bourgeois; H Van Vlierberghe; T Sersté; S Francque; P Michielsen; D Sprengers; H Reynaert; J Henrion; S Negrin Dastis; J Delwaide; L Lasser; J Decaestecker; H Orlent; F Janssens; G Robaeys; I Colle; P Stärkel; C Moreno; F Nevens; T Vanwolleghem
Journal:  Aliment Pharmacol Ther       Date:  2018-03-02       Impact factor: 8.171

View more
  17 in total

Review 1.  Risks and benefits of oral HIV pre-exposure prophylaxis for people with chronic hepatitis B.

Authors:  Amir M Mohareb; Joseph Larmarange; Arthur Y Kim; Patrick A Coffie; Menan Gérard Kouamé; Anders Boyd; Kenneth A Freedberg; Emily P Hyle
Journal:  Lancet HIV       Date:  2022-07-08       Impact factor: 16.070

Review 2.  A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook.

Authors:  Anna Kramvis; Kyong-Mi Chang; Maura Dandri; Patrizia Farci; Dieter Glebe; Jianming Hu; Harry L A Janssen; Daryl T Y Lau; Capucine Penicaud; Teresa Pollicino; Barbara Testoni; Florian Van Bömmel; Ourania Andrisani; Maria Beumont-Mauviel; Timothy M Block; Henry L Y Chan; Gavin A Cloherty; William E Delaney; Anna Maria Geretti; Adam Gehring; Kathy Jackson; Oliver Lenz; Mala K Maini; Veronica Miller; Ulrike Protzer; Jenny C Yang; Man-Fung Yuen; Fabien Zoulim; Peter A Revill
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-07-20       Impact factor: 73.082

3.  Highly multiplexed 2-dimensional imaging mass cytometry analysis of HBV-infected liver.

Authors:  Daniel Traum; Yue J Wang; Kathleen B Schwarz; Jonathan Schug; David Kh Wong; Harry LA Janssen; Norah A Terrault; Mandana Khalili; Abdus S Wahed; Karen F Murray; Phillip Rosenthal; Simon C Ling; Norberto Rodriguez-Baez; Richard K Sterling; Daryl Ty Lau; Timothy M Block; Michael D Feldman; Elizabeth E Furth; William M Lee; David E Kleiner; Anna S Lok; Klaus H Kaestner; Kyong-Mi Chang
Journal:  JCI Insight       Date:  2021-04-08

4.  Clinical cure and liver fibrosis reversal after postoperative antiviral combination therapy in hepatitis B-associated non-cirrhotic hepatocellular carcinoma: A case report.

Authors:  Xue-Ping Yu; Qi Lin; Zhi-Peng Huang; Wei-Shan Chen; Ming-Hui Zheng; Yi-Juan Zheng; Ju-Lan Li; Zhi-Jun Su
Journal:  World J Clin Cases       Date:  2021-01-26       Impact factor: 1.337

Review 5.  Hepatitis B Flare in Hepatitis B e Antigen-Negative Patients: A Complicated Cascade of Innate and Adaptive Immune Responses.

Authors:  Ming-Ling Chang; Yun-Fan Liaw
Journal:  Int J Mol Sci       Date:  2022-01-28       Impact factor: 5.923

6.  Follow-Up of 108 Patients with Chronic Hepatitis B Virus Infection Treated with Polyethylene Glycol-Conjugated Derivatives of Interferon-Alpha and Monitoring of Off-Treatment Virological Relapse.

Authors:  Liyang Zhou; Qin He; Xitao Liu; Xiaoan Yang; Xueting Ou; Bing Situ; Yueping Li; Xingfei Pan; Qihuan Xu
Journal:  Med Sci Monit       Date:  2022-03-30

7.  CD155/SRC complex promotes hepatocellular carcinoma progression via inhibiting the p38 MAPK signalling pathway and correlates with poor prognosis.

Authors:  An-Li Jin; Chun-Yan Zhang; Wen-Jing Zheng; Jing-Rong Xian; Wen-Jing Yang; Te Liu; Wei Chen; Tong Li; Bei-Li Wang; Bai-Shen Pan; Qian Li; Jian-Wen Cheng; Peng-Xiang Wang; Bo Hu; Jian Zhou; Jia Fan; Xin-Rong Yang; Wei Guo
Journal:  Clin Transl Med       Date:  2022-04

8.  Diagnostic performance of individual characteristics and anthropometric measurements in detecting elevated serum alanine aminotransferase among children and adolescents.

Authors:  Yu-Lan Ou; Yue-Rong Lai; Chao-Nan Jiang; Jing Zhang; Zan Ding
Journal:  BMC Pediatr       Date:  2020-03-20       Impact factor: 2.125

Review 9.  Humoral immunity in hepatitis B virus infection: Rehabilitating the B in HBV.

Authors:  Thomas Vanwolleghem; Tom Adomati; Stijn Van Hees; Harry L A Janssen
Journal:  JHEP Rep       Date:  2021-11-19

10.  Making safe sense of an anti-sense!

Authors:  Upkar S Gill; Maud Lemoine
Journal:  Cell Rep Med       Date:  2022-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.